Immunotherapy AdvancesImmunologyPeer-reviewed journal article
Interaction with tumor cell spheroids induces suppression in primary human cytotoxic T cells
Amal Alsubaiti, Hanin AlamiriD, Lan Huynh, Tressan GrantiD, Abdullah Aljohani, Po Han Chou, Yiwei Shi, Maryam Alismail, Lydia R Mason, Andrew Herman, John S. BridgemaniD, Christopher J. Holland, Christoph WülfingiD
Abstract
Cytotoxic T lymphocytes (CTL) are key effectors in the anti-tumor immune response. However, their function is commonly suppressed in tumors in the form of exhausted CTL. Understanding molecular mechanisms of suppression and of therapeutics to overcome them is of substantial basic and translational importance yet hindered by limited access to large numbers of exhausted CTL in vitro. Here we use three-dimensional tissue culture to generate primary human CTL with suppressed function. Using a 21-antibody flow cytometry panel and determination of calcium signaling and cell couple maintenance, we show that these cells closely resemble exhausted CTL from tumors. For better understanding of in vitro human primary CTL as key tools in therapeutic development, before and after induction of suppression, we have determined the dependence of CTL function on technicalities of in vitro CTL generation, antigen dose and affinity across two T cell receptors and multiple tumor cell lines. We have investigated morphology and subcellular F-actin distributions of CTL as a key regulators of effector function. Primary human CTL formed cell couples with tumor target cells even in the absence of antigen. Yet, gradual stabilization of such cell couples was associated with increasing CTL effector function. Induction of suppression substantially destabilized CTL tumor cell couples. This comprehensive characterization of the phenotype of in vitro primary human CTL, including a suppressed state, should facilitate their wider use in basic and translational research.
- organism: human
- assay: flow cytometry
- research focus: cell type annotation
- research focus: cell signaling & trafficking
- research focus: cancer & tumor microenvironment
- approach: experimental assay
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 32th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- TIM3 is a context-dependent co-regulator of cytotoxic T cell function
H. Alamir, C. W. C. Wong, … C. Wuelfing·bioRxiv·Aug 3, 2023
- Intratumoral immune triads are required for adoptive T cell therapy-mediated elimination of solid tumors
A. Schietinger, G. Espinosa-Carrasco, … M. Hellmann·bioRxiv·Jul 3, 2023
- The adenosine 2a receptor and TIM3 directly inhibit killing of tumor cells by cytotoxic T lymphocytes through interference with cytoskeletal polarization
G. L. Edmunds, C. W. L. Wong, … D. J. Morgan·bioRxiv·May 20, 2021
- TCF-7 is dispensable for the anti-tumor response but required for the persistent function of mature CD8 T cells
R. Harris, M. Mammadli, … M. Karimi·bioRxiv·Mar 22, 2021
- CD137-stimulated cytotoxic T lymphocytes exert superior tumour control due to an enhanced antimitotic effect on tumour cells
R. Beck, B. Weigelin, J. Beltman·bioRxiv·Dec 15, 2020
- Human effector CD8+ T cells with an exhausted-like phenotype control tumor growth in vivo in a humanized tumor model
J. Mietz, M. Kaulfuss, … O. Chijioke·bioRxiv·Oct 11, 2023